Oramed Pharmaceuticals (ORMP) EBITDA (2009 - 2026)
Oramed Pharmaceuticals' EBITDA was -$2.74 million in Q2 2026, compared with -$2.46 million a year earlier.
Powered by 
Analysis
Oramed Pharmaceuticals (ORMP) EBITDA (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Oramed Pharmaceuticals' EBITDA was -$14.4 million through Jun 30, 2026; for FY2025, it came in at -$14.97 million.
- In earlier years, EBITDA was -$12.59 million in FY2024, -$15.57 million in FY2023, -$40.54 million in FY2022 and $12.27 million in FY2021.
- Quarterly EBITDA has moved between -$12.31 million (Q4 2022) and -$2.4 million (Q3 2025) over five years.
- Per Business Quant data, ORMP's EBITDA in the three quarters before Q2 2026 was -$3.63 million (Q1 2026), -$5.64 million (Q4 2025) and -$2.4 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 7.34 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 5.99 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Oramed Pharmaceuticals | 164.02 Mn | -170.72 Mn | - | -2.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.74 Mn |
| Mar 31, 2026 | -3.63 Mn |
| Dec 31, 2025 | -5.64 Mn |
| Sep 30, 2025 | -2.40 Mn |
| Jun 30, 2025 | -2.46 Mn |
| Mar 31, 2025 | -4.47 Mn |
| Dec 31, 2024 | -3.56 Mn |
| Sep 30, 2024 | -3.04 Mn |
| Jun 30, 2024 | -3.08 Mn |
| Mar 31, 2024 | -2.91 Mn |
| Dec 31, 2023 | -3.82 Mn |
| Sep 30, 2023 | -2.84 Mn |
| Jun 30, 2023 | -3.74 Mn |
| Mar 31, 2023 | -5.17 Mn |
| Dec 31, 2022 | -12.31 Mn |
| Sep 30, 2022 | -8.17 Mn |
| Jun 30, 2022 | -11.40 Mn |
| Mar 31, 2022 | -11.24 Mn |
| Nov 30, 2021 | 8.07 Mn |
| Feb 28, 2021 | 4.90 Mn |
API Access
Oramed Pharmaceuticals EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=ORMP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "ORMP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=ORMP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();